Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Death triggers pause of 2seventy CAR-T cell therapy leukemia trial
Fierce Biotech
Wed, 06/14/23 - 10:18 am
2seventy bio
Bluebird Bio
CAR-T
patient death
clinical trials
AML
ASCO 2023: Precigen reports positive early data for CAR-T therapy
BioSpace
Tue, 06/6/23 - 11:12 am
ASCO 2023
Precigen
CAR-T
PRGN-3005
ovarian cancer
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
China dominates CAR-T therapies
Clinical Trials Arena
Thu, 06/1/23 - 11:25 am
China
cancer
CAR-T
ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?
Fierce Pharma
Fri, 05/26/23 - 09:57 am
ASCO 2023
Bristol Myers Squibb
Breyanzi
CAR-T
CLL
SLL
clinical trials
J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies
BioSpace
Tue, 05/2/23 - 11:46 am
JNJ
Janssen
Cellular Biomedicine
CAR-T
diffuse large B-cell lymphoma
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
Caribou gets FDA fast track for allogeneic CAR-T
Biopharma Reporter
Tue, 04/11/23 - 10:02 am
Caribou Biosciences
FDA
Multiple Myeloma
CAR-T
CB-011
Gilead’s Yescarta extends survival in lymphoma study
BioPharma Dive
Tue, 03/21/23 - 09:53 pm
Gilead Sciences
Yescarta
CAR-T
lymphoma
large B-cell lymphoma
Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls
Fierce Pharma
Wed, 03/15/23 - 09:27 pm
JNJ
Legend Biotech
CAR-T
Carvykti
Cancer drug startup Cargo raises $200M to solve CAR-T relapse
BioPharma Dive
Thu, 03/2/23 - 10:28 am
Cargo Therapeutics
lymphoma
CAR-T
OCI-led CAR-T leukemia therapy receives €2.5m from EIC
Pharmaphorum
Mon, 02/27/23 - 07:02 pm
OneChain
Europe
CAR-T
leukemia
Bristol Myers details landmark Abecma multiple myeloma data that ASH turned down
Fierce Pharma
Sun, 02/12/23 - 07:46 pm
Bristol Myers Squibb
Abecma
CAR-T
Multiple Myeloma
Bristol Myers claims win with CAR-T therapy Breyanzi in leukemia
Endpoints
Thu, 01/26/23 - 05:09 pm
Bristol Myers Squibb
CAR-T
Breyanzi
CLL
cell therapy
After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE
Fierce Pharma
Thu, 01/26/23 - 10:40 am
Gilead Sciences
CAR-T
Yescarta
UK
NICE
Kite Pharma
Novartis
blood cancer
Kite swoops in to buy Carl June-founded Tmunity, gaining key to Penn's CAR-T research apparatus
Fierce Biotech
Tue, 12/20/22 - 11:17 am
Kite Pharma
Gilead Sciences
M&A
CAR-T
Tmunity
Carl June
ASH: Novartis stays the course with cell therapy bet as competitors line up 'off-the-shelf' options
Fierce Biotech
Tue, 12/13/22 - 10:36 am
Novartis
ASH 2022
CAR-T
T-Charge
ASH: In next BCMA myeloma race, Gracell dazzles with 100% response rate as Pfizer, BMS place their bets
Fierce Biotech
Mon, 12/12/22 - 10:33 am
ASH 2022
Gracell
CAR-T
Multiple Myeloma
Bristol Myers Squibb
Pfizer
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead
Fierce Pharma
Mon, 12/12/22 - 10:16 am
Bristol Myers Squibb
Breyanzi
B-cell lymphoma
CAR-T
ASH 2022
With Neogene buy and a CAR-T in the clinic, AstraZeneca builds up cell therapy 'library'
Fierce Biotech
Mon, 12/5/22 - 11:04 am
AstraZeneca
Neogene Therapeutics
CAR-T
cell therapy
cell library
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »